1D
0.96%
0.59%
1W
-0.45%
-0.06%
1M
-8.38%
2.3%
YTD
-1.56%
10.75%
1Y
-4.5%
5.98%
3Y
0.17%
40.03%
5Y
-19.59%
97.51%
10Y
%
236.5%
- Stock Absolute Returns
- Absolute Returns
Total Returns (Price + Dividend) 
Dividend Yield (1.04%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-7.43%
0%
-7.43%
6 Months
7.22%
1.08%
8.3%
1 Year
-4.5%
1.01%
-3.49%
2 Years
-3.27%
2.07%
-1.2%
3 Years
0.17%
2.40%
2.57%
4 Years
-52.0%
0.98%
-51.02%
5 Years
-19.59%
1.55%
-18.04%
Latest dividend: 18 per share ex-dividend date: Aug-14-2025
What is a Quartile?
Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.
Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on
Return Quartiles - by Closest Peers 
Underperformer
Gland Pharma Ltd has been in the Third and Fourth Quartile in the YTD and longer periods
4
Quartile
QTD
-12.05%
1
Quartile
Jun-Sep
8.62%
2
Quartile
Mar-Jun
15.15%
3
Quartile
YTD
-3.4%
4
Quartile
2024
-7.54%
4
Quartile
2023
22.07%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry 
Inconsistent Performance
Gland Pharma Ltd has not been a consistent performer in the YTD and longer periods
3
Quartile
QTD
-12.05%
1
Quartile
Jun-Sep
8.62%
2
Quartile
Mar-Jun
15.15%
2
Quartile
YTD
-3.4%
4
Quartile
2024
-7.54%
3
Quartile
2023
22.07%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap 
Not enough Stock Price history for Quartile Analysis
Risk Adjusted Returns v/s 
Returns Beta
Beta has not been calculated since enough price history is not available






